Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential

Cell Reports(2021)10.1016/j.celrep.2021.109838Source: DataRank Database

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (49)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Yu Jui Kung,John Lin ORCID,Ssu-Hsueh Tseng,Ya Chea Tsai,Liangmei He

Live enrichment

PubMed:34648735 PMC:PMC8491932

National Institutes of Health

Grant: 5F31CA236051

National Institutes of Health

Grant: 5P50CA098252

NCI NIH HHS

Grant: F31 CA236051

NCI NIH HHS

Grant: R01 CA237067

NCI NIH HHS

Grant: P50 CA098252

National Institutes of Health

Grant: 5P50CA098252-17

SPORE in Cervical Cancer

National Institutes of Health

Grant: 1F31CA236051-01

The role of Albumin-Flt3L-induced cross-presenting dendritic cell expansion in antitumor immunity

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.celrep.2021.109838

publisherhttps://api.elsevier.com/content/article/PII:S2211124721013024?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124721013024?httpAccept=text/plain

repositoryhttps://doaj.org/article/71e3dc14b5b146a39a33944e1256682a

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8491932

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

NasopharynxCell LineImmune SystemAnimalsHumansMiceRecombinant ProteinsAntibodies, ViralImmunization, PassiveProtein BindingMutationCricetinaeGenetic VariationAntibodies, NeutralizingHEK293 CellsSpike Glycoprotein, CoronavirusIn Vitro TechniquesCOVID-19SARS-CoV-2COVID-19 Serotherapy

Keywords

Immune escapePseudovirusCovid-19Sars-cov-2N501yIn vivo ModelingQH301-705.5In Vitro TechniquesAntibodies, ViralArticleCell LineMiceCricetinaeNasopharynxAnimalsHumansBiology (General)COVID-19 SerotherapyImmunization, PassiveGenetic VariationAntibodies, NeutralizingRecombinant ProteinsHEK293 CellsImmune SystemMutationSpike Glycoprotein, CoronavirusProtein Binding

Sustainable Development Goals

SDG 3: 3. Good health

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential

FAIR Checklist

Authors (15)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)